UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$584.10−3.78 (-0.64%)
Close on Nov 17, 2026Market cap $25.05BP/E 20.9Yield –
United Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2013 it was $3.72M, down 94.7% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $3.72M | -94.7% |
| FY2012 | Dec 31, 2012 | $70.34M | -1.6% |
| FY2011 | Dec 31, 2011 | $71.45M | +3.7% |
| FY2010 | Dec 31, 2010 | $68.93M | – |
See a number that looks wrong?